CYDY CytoDyn Inc

Price (delayed)

$1.665

Market cap

$1.02B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.33

Enterprise value

$1.04B

Highlights
The debt has declined by 24% since the previous quarter
CytoDyn's equity has shrunk by 142% QoQ
CytoDyn's net income has shrunk by 105% YoY and by 5% QoQ

Key stats

What are the main financial stats of CYDY
Market
Shares outstanding
612.88M
Market cap
$1.02B
Enterprise value
$1.04B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$164.19M
EBITDA
-$162.16M
Free cash flow
-$114.18M
Per share
EPS
-$0.33
Free cash flow per share
-$0.2
Book value per share
-$0.03
Revenue per share
$0
TBVPS
$0.19
Balance sheet
Total assets
$113.65M
Total liabilities
$129.45M
Debt
$38.75M
Equity
-$15.8M
Working capital
-$18.01M
Liquidity
Debt to equity
-2.45
Current ratio
0.86
Quick ratio
0.11
Net debt/EBITDA
-0.15
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-166.9%
Return on equity
N/A
Return on invested capital
-1,165.3%
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CYDY stock price

How has the CytoDyn stock price performed over time
Intraday
-7.5%
1 week
17.25%
1 month
-0.3%
1 year
-70.69%
YTD
-69.11%
QTD
-2.06%

Financial performance

How have CytoDyn's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$108.68M
Net income
-$167.39M
Gross margin
N/A
Net margin
N/A
CytoDyn's net income has shrunk by 105% YoY and by 5% QoQ
The operating income has dropped by 79% year-on-year and by 9% since the previous quarter

Growth

What is CytoDyn's growth rate over time

Valuation

What is CytoDyn stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has dropped by 57% year-on-year
CytoDyn's equity has shrunk by 142% QoQ

Efficiency

How efficient is CytoDyn business performance
The company's return on assets has surged by 51% YoY and by 14% QoQ
CYDY's return on invested capital is up by 42% since the previous quarter

Dividends

What is CYDY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CYDY.

Financial health

How did CytoDyn financials performed over time
CYDY's total assets is 12% smaller than its total liabilities
The company's total liabilities has surged by 200% YoY but it fell by 14% QoQ
CYDY's total assets has surged by 193% year-on-year but it is down by 21% since the previous quarter
CytoDyn's debt to equity has shrunk by 161% YoY but it has surged by 69% QoQ
CytoDyn's equity has shrunk by 142% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.